SEC Form 4 · accession 0001179110-18-012635

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President

Period of report

Nov 5, 2018

Accepted (ET)

Nov 7, 2018 · 4:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F2	Nov 5, 2018	M	12,692	—	A	12,692	D
Common Stock	Nov 5, 2018	M	56,532	$32.50	A	69,224	D
Common Stock^F1,F3	Nov 5, 2018	S	69,224	$66.77	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F4,F5	—	Nov 5, 2018	M	12,692	D	—	—	Common Stock	12,692	38,077	D
Employee Stock Option (right to buy)^F6	$32.50	Nov 5, 2018	M	56,532	D	—	Nov 3, 2027	Common Stock	56,532	169,596	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 11, 2018.
F2Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3Represents the weighted average price of transactions ranging from $65.38 to $72.31. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F5On November 3, 2017, the reporting person was was granted 50,769 restricted stock units, vesting in four equal annual installments beginning on November 3, 2018.
F6The option vests as to 25% of the shares on November 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.